Value of triple H therapy in a patient with an ischemic penumbra following subarachnoid hemorrhage: a case study.
We report the case of a 43-year-old patient with delayed ischemic neurological deficit and an ischemic penumbra, reversed with triple H therapy (hypertension, hypervolemia, and hemodilution). The patient presented with subarachnoid hemorrhage caused by an aneurysm of the anterior communicating artery. He underwent surgical clipping and developed cerebral ischemia due to vasospasm. Permanent damage to the area of ischemic brain was prevented by institution of the triple H therapy. He recovered and was discharged with no subsequent neurological deficits.
Ogungbo
Biodun
B
James Cook University Hospital, Middlesbrough, United Kingdom. Biodun-ogungbo@supanet.com
Prakash
Savithru
S
Ushewokunze
Shungu
S
Etherson
Kevin
K
Sinar
John
J
D000328:Adult; D002545:Brain Ischemia / Q000209:etiology / Q000473:pathology / Q000628:therapy*; D003131:Combined Modality Therapy; D005440:Fluid Therapy / Q000379:methods; D006438:Hemodilution / Q000379:methods; D006801:Humans; D006973:Hypertension; D008297:Male; D013345:Subarachnoid Hemorrhage / Q000150:complications*; D020301:Vasospasm, Intracranial / Q000150:complications